Browse Studies — Arctuva

Phase 2

Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II

The goal of this clinical trial is to compare antiviral treatment strategies for cytomegalovirus (CMV) anterior uveitis - a viral infection causing inflammatio…

Cytomegalovirus (CMV)Anterior UveitisInfectious Uveitis+1 more

Estimated

~$10 – $5,625

University of California, San FranciscoNCT07513623

Phase 2

Phase 2, Randomized, Open-label, Active Comparator, Dose-ranging Study Evaluating the Efficacy and Safety of Artesunate for Injection in Combination With Ganciclovir or Valganciclovir for the Treatment of Cytomegalovirus Infection in Solid Organ Transplant Recipients

This study is a randomized, open-label, active comparator-controlled, dose-ranging trial of the efficacy and safety of IV artesunate in combination with IV GCV…

CMV Infection

Estimated

~$10 – $8,750

Amivas Inc.NCT06853184

Phase 4

Letermovir Versus Valganciclovir for 90 Days in CMV Seropositive Kidney Transplant Recipients: Results of a Single-center Experience.

The purpose of this study is to find out whether letermovir can help prevent cytomegalovirus (CMV) infection in kidney transplant recipients who are CMV seropo…

CMV InfectionCMVCMV Viremia+1 more

Estimated

~$10 – $8,750

Elisabeth KincaideNCT07571135

Prospective Observational Study of Asymptomatic cCMV Transmission to Infants for Virological Evaluation in New York State

PROACTIVE NYS is a long-term follow-up study of all infants who test positive for congenital Cytomegalovirus infection (CMV) throughout New York State on the N…

Congenital CMV InfectionSensorineural Hearing Loss

Estimated

~$10 – $750

Stony Brook UniversityNCT06226558